David A Janowick

Title: David A. Janowick: Innovator in Pharmaceutical Compounds

Introduction

David A. Janowick is a notable inventor based in Quincy, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have therapeutic applications. His work focuses on innovative solutions for treating serious health conditions.

Latest Patents

Janowick holds a patent for "Quinazoline and quinoline compounds and uses thereof." This invention provides compounds of formula (I) or a pharmaceutically acceptable salt thereof, wherein T, J, R, R, R, o, R, W, and R are as described in the specification. The compounds are inhibitors of NAMPT and are thus useful for treating cancer, inflammatory conditions, and/or T-cell mediated autoimmune disease. He has 1 patent to his name.

Career Highlights

David A. Janowick is associated with Millennium Pharmaceuticals Limited, where he has been instrumental in advancing pharmaceutical research and development. His expertise in creating innovative compounds has positioned him as a valuable asset in the industry.

Collaborations

Throughout his career, Janowick has collaborated with notable colleagues, including Brian Scott Freeze and Kenneth M. Gigstad. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries.

Conclusion

David A. Janowick's contributions to pharmaceutical innovations demonstrate his commitment to improving healthcare through science. His work in developing compounds for treating critical diseases highlights the importance of innovation in the medical field.